| Bioactivity | HJC0152 (free base) is an orally active and potent inhibitor of STAT3. HJC0152 (free base) inhibits cell cycle progression and induces apoptosis. HJC0152 (free base) significantly suppresses MDA-MB-231 xenograft tumor growth in mice[1]. |
| Name | HJC0152 free base |
| CAS | 1420290-88-5 |
| Formula | C15H13Cl2N3O4 |
| Molar Mass | 370.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chen H, et al. Discovery of O-Alkylamino Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents. ACS Med Chem Lett. 2013 Feb 14;4(2):180-185. |
HJC0152 free base
CAS: 1420290-88-5 F: C15H13Cl2N3O4 W: 370.19
HJC0152 (free base) is an orally active and potent inhibitor of STAT3. HJC0152 (free base) inhibits cell cycle progressi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.